Here, we investigated the expression of the TET2 gene in healthy human progenitor T cells, pediatric T-ALL patients, and T-ALL cell lines, revealing that TET2 was frequently silenced in T-ALL and that silencing was associated with aberrant hypermethylation of the TET2 promoter. This evidence concerns the gene TET2 and acute lymphoblastic leukemia.